Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy - An echocardiographic study

被引:26
|
作者
Santagata, P
Rigo, F
Gherardi, S
Pratali, L
Drozdz, J
Varga, A
Picano, E
机构
[1] CNR, Inst Clin Physiol, I-56124 Pisa, Italy
[2] Univ Szeged, Szeged, Hungary
[3] Univ Lodz, PL-90131 Lodz, Poland
关键词
coronary flow reserve; dilated carchomyopathy; dipyridamole; echocardiography;
D O I
10.1016/j.ijcard.2004.11.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary flow reserve (CFR) is impaired in non-ischemic dilated cardiomyopathy (DCM). Mechanisms by which such impairment occurs are still unknown, but cofactors; such as diastolic compressive force, left ventricular hypertrophy, and microvascular disease have been implied. In order to characterize the determinants of CFR in non-ischemic DCM, we evaluated 110 non-ischemic DCM patients (58 men; age=61 +/- 12 years) and 21 age- and gender-matched control patients (14 men; age=59 +/- 13 years) by transthoracic (n=88) or transesophageal (n=22) dipyridamole (0.84 mg/kg in 10') stress echocardiography. All patients showed angiographically normal coronary arteries. Non-ischemic DCM patients had an ejection fraction < 45% while control patients had normal left ventricular systolic function. CFR was assessed on LAD by pulsed Doppler as the ratio of maximal vasodilation (dipyridamole) to rest peak diastolic coronary flow velocity. Mean CFR value was 2.0 +/- 0.6 for DCM patients and 3.2 +/- 0.5 for controls (p < 0.01). At individual non-ischemic DCM patient analysis, 46 patients had normal CFR >= 2 (Group 1) and 64 patients had abnormal CFR < 2 (Group 2). On univariate analysis, CFR reduction correlated with NYHA functional class (r=-0.33, p=0.001), left ventricular ejection fraction ( r=0.23, p=0.02), end-systolic volume (r=-0.23, p=0.02), systolic pulmonary artery pressure (r=-0.42, p=0.0001), deceleration time (r=0.24, p=0.02). Logistic multiregression analysis showed that only NYHA functional class significantly and negatively correlated with CFR (odds ratio=0.9; 95% confidence intervals: 0.03-.35, p=0.0001). In patients with non-ischemic DCM, CFR is reduced but with substantial individual variability, only partially accounted for by level of systolic and diastolic dysfunction. The clinical functional class is the strongest predictor of CFR reduction in these patients, with lowest flow reserve found in more advanced NYHA class. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [31] Non-ischemic dilated cardiomyopathy and cardiac fibrosis
    Cojan-Minzat, Bianca Olivia
    Zlibut, Alexandru
    Agoston-Coldea, Lucia
    HEART FAILURE REVIEWS, 2021, 26 (05) : 1081 - 1101
  • [32] ECHOCARDIOGRAPHIC EVALUATION OF FUNCTIONAL MITRAL REGURGITATION IN NON ISCHEMIC DILATED CARDIOMYOPATHY
    Karaca, Oguz
    Avci, Anil
    Guler, Gamze Babur
    Guler, Ekrem
    Alizade, Elnur
    Gol, Gokhan
    Gunes, Haci Murat
    Esen, Ozlem
    Esen, Ali Metin
    Turkmen, Muhsin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 140 : S28 - S29
  • [33] Clinical and functional determinants of coronary flow reserve in heart transplantation: A contrast-enhanced echocardiographic study
    Tona, F.
    Caforio, A. L. P.
    Montisci, R.
    Gambino, A.
    Feltrin, G.
    Dequal, G.
    Ramondo, A.
    Angelini, A.
    Gerosa, G.
    Iliceto, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S151 - S151
  • [34] Clinical and functional determinants of coronary flow reserve in heart transplantation: a contrast-enhanced echocardiographic study
    Tona, Francesco
    Caforio, Alida L.
    Montisci, Roberta
    Gambino, Antonio
    Ruscazio, Massimo
    Sarais, Cristiano
    Ramondo, Angelo
    Angelini, Annalisa
    Gerosa, Gino
    Iliceto, Sabino
    CIRCULATION, 2006, 114 (18) : 363 - 363
  • [35] Clinical outcomes in cardiac arrest survivors with coronary artery disease versus non-ischemic dilated cardiomyopathy
    Chow, T
    Albert, C
    Kelly, E
    Simpson, E
    Ruskin, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 293A - 293A
  • [36] Shared Genetic Burden of Ischemic and Non-Ischemic Dilated Cardiomyopathy
    Cao, Louie
    Rushakoff, Joshua
    Zhang, Zijun
    Williamson, Ian
    Karlstaedt, Anja
    Kittleson, Michelle
    Czer, Lawrence
    Kransdorf, Evan
    CIRCULATION, 2024, 150
  • [37] The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy
    Tigen, Kursat
    Karaahmet, Tansu
    Kirma, Cevat
    Kilicgedik, Alev
    Dundar, Cihan
    Pala, Selcuk
    Cevik, Cihan
    Guler, Ahmet
    Gurel, Emre
    Basaran, Yelda
    CARDIOLOGY JOURNAL, 2010, 17 (03) : 274 - 280
  • [38] Clinical determinants of mortality in patients with angiographically proven ischemic and non-ischemic cardiomyopathy
    Bart, BA
    Shaw, LK
    McCants, CB
    Fortin, DF
    Lee, KL
    OConnor, CM
    CIRCULATION, 1996, 94 (08) : 1121 - 1121
  • [39] The association of functional mitral regurgitation and anemia in patients with non-ischemic dilated cardiomyopathy
    Tigen, K.
    Karaahmet, T.
    Kirma, C.
    Kilicgedik, A.
    Dundar, C.
    Pala, S.
    Cevik, C.
    Guler, A.
    Gurel, E.
    Basaran, Y.
    EUROPEAN HEART JOURNAL, 2010, 31 : 631 - 631
  • [40] Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
    Rieger, Angela C.
    Myerburg, Robert J.
    Florea, Victoria
    Tompkins, Bryon A.
    Natsumeda, Makoto
    Premer, Courtney
    Khan, Aisha
    Schulman, Ivonne H.
    Vidro-Casiano, Mayra
    DiFede, Darcy L.
    Heldman, Alan W.
    Mitrani, Raul
    Hare, Joshua M.
    EBIOMEDICINE, 2019, 48 : 377 - 385